Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Taysha gene therapies, inc. source : Www.biospace.com save search
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 2, 2024
Published: 2024-02-02 (Crawled : 14:30) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: -1.28%
H: 1.3%
C: -1.95%
nasdaq grant
GordonMD® Invests in Private Placement for Taysha Gene Therapies
Published: 2023-08-21 (Crawled : 18:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 1.04%
H: 8.76%
C: -1.03%
gordonmd
Taysha Gene Therapies Provides Update on TSHA-120 Program in Giant Axonal Neuropathy and a 2023 Corporate Outlook
Published: 2023-01-31 (Crawled : 00:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 0.65%
H: 10.32%
C: 5.81%
tsha-120 program update
Taysha Gene Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-08 (Crawled : 20:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 1.0%
H: 10.4%
C: 8.91%
financial update results
Taysha Gene Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -19.06%
update results
Taysha Gene Therapies to Participate in Upcoming August Investor Conferences
Published: 2022-08-01 (Crawled : 00:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: -1.97%
H: 8.76%
C: 2.76%
Taysha Gene Therapies Announces Annual Stockholder MeetingThe Annual Stockholder Meeting on Friday, June 17, 2022 at 10 am ET
Published: 2022-06-13 (Crawled : 22:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: -4.48%
H: 0.0%
C: -14.38%
therapy
Taysha Gene Therapies to Release First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 16
Published: 2022-05-11 (Crawled : 12:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 1.66%
H: 10.33%
C: -13.32%
conference results therapy
Taysha Gene Therapies Receives Orphan Drug Designation from the European Commission for TSHA-120 for the Treatment of Giant Axon Neuropathy (GAN)
Published: 2022-05-03 (Crawled : 13:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 5.0%
H: 9.02%
C: 7.52%
tsha-120 treatment designation drug
Taysha Gene Therapies Announces Oral Presentations at the Upcoming 2022 IRSF Rett Syndrome Scientific Symposium and the ASCEND National Summit
Published: 2022-04-25 (Crawled : 15:20) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: -0.43%
H: 4.29%
C: 2.15%
symposium therapy rett syndrome
Taysha Gene Therapies Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-31 (Crawled : 12:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 0.0%
H: 15.08%
C: 6.02%
results therapy
Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-102 in Rett Syndrome
Published: 2022-03-29 (Crawled : 12:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 1.72%
H: 5.76%
C: 3.05%
tsha-102 therapy rett syndrome
Taysha Gene Therapies to Release Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 31
Published: 2022-03-24 (Crawled : 12:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 1.94%
H: 1.9%
C: -1.27%
conference results
Taysha Gene Therapies Reports Positive Clinical Efficacy and Safety Data for High Dose Cohort and Long-term Durability Data for TSHA-120 in Giant Axonal Neuropathy
Published: 2022-01-31 (Crawled : 15:30) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 3.62%
H: 8.2%
C: 6.85%
tsha-120 gene therapies report positive gene therapy
Taysha Gene Therapies Announces Positive Initial Biomarker Data For TSHA-101
Published: 2022-01-27 (Crawled : 12:30) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 2.88%
H: 1.27%
C: -13.34%
tsha-101 gene therapies positive gene therapy therapy biomarkers tsha-102
Taysha Gene Therapies to Present at the 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-06 (Crawled : 12:30) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: -1.38%
H: 2.52%
C: 1.77%
health thc conference gene therapies j.p. morgan healthcare conference gene therapy therapy
Taysha Gene Therapies to Participate in Panel Discussions at the LifeSci Partners 11th Annual Corporate Access Event
Published: 2022-01-03 (Crawled : 13:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 3.09%
H: 0.0%
C: -1.25%
gene therapies gene therapy therapy
Taysha Gene Therapies Announces January 2022 Virtual Investor Events to Review Preliminary Clinical Data for TSHA-101 in GM2 Gangliosidosis and High Dose Cohort and Long-Term Clinical Data for TSHA-120 in Giant Axonal Neuropathy
Published: 2021-12-28 (Crawled : 13:00) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 0.08%
H: 4.97%
C: -5.52%
tsha-101 gene therapies gene therapy tsha-102
Taysha Gene Therapies Added to the ICE Biotechnology Index
Published: 2021-12-23 (Crawled : 12:30) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: 1.37%
H: 0.0%
C: -4.49%
technology gene therapies index biotech iot therapy gene therapy
Taysha Gene Therapies Announces Positive Preliminary Clinical Safety Data For First-Generation Construct In CLN7 Disease and Completion of Next-Generation CLN7 Construct Design
Published: 2021-12-22 (Crawled : 12:30) - biospace.com/
TSHA | $2.525 2.64% 2.57% 1.5M
|
Health Technology
|
| O: -0.59%
H: 1.04%
C: -2.01%
disease gene therapies positive gene therapy designation
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.